Back to EGF+61 genetic polymorphisms and lung cancer risk: looking to the future!

por Mello, Ramon Andrade De
Publicado 2013

Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer

por Zhu, Guangsheng, Ren, Dian, Lei, Xi, Shi, Ruifeng, Zhu, Shuai, Zhou, Ning, Zu, Lingling, Mello, Ramon Andrade De, Chen, Jun, XU, Song
Publicado 2021